A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

A pioneering test is improving early diagnosis for people with hereditary cancer caused by a genetic condition. Just over 30 ...

A new, simple blood test could transform breast cancer treatment by accurately matching women to the right therapies and tracking the disease's evolution, potentially eliminating the need for invasive ...

Pat Grant's inoperable cancer diagnosis made her think she would never meet her first grandchild.

Urological cancers like bladder, prostate, and kidney cancer often go unnoticed until they become advanced. Traditional screening tools, such as PSA tests, biopsies, and imaging, can be invasive and ...

A pioneering genetic test is improving early diagnosis and treatment for people with hereditary cancer caused by a genetic condition. The test, developed with the help of Newcastle University ...

Breast cancer is one of the most prevalent cancers in the world. The World Health Organization (WHO) says that there were an estimated 2.3 million women diagnosed with breast cancer in 2022. It also ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...

There is increased stress on screening for cancers. If there is one medical entity where early detection truly saves lives, it is in screening for cancers. Cervical cancer now stands as the second ...